29.01.2019 20:30:00

Global Pharma Academic and Non-Profit Partnering Report 2018: Access to Actual Contracts by Leading Biopharma Companies Since 2012

DUBLIN, Jan. 29, 2019 /PRNewswire/ --

The "Global Academic and Non-Profit Partnering Terms and Agreements 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

Global Academic and Non-Profit Partnering Terms and Agreements 2012 to 2018 report provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes. This report provides details of the latest Academic and Non-Profit agreements announced in the life sciences since 2012.

The report takes the reader through a comprehensive review Academic and Non-Profit deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Academic and Non-Profit partnering deals.

The report presents financial deal term values for Academic and Non-Profit deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Academic and Non-Profit partnering field; both the leading deal values and most active Academic and Non-Profit dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 4,000 online deal records of actual Academic and Non-Profit deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

Key benefits

  • In-depth understanding of Academic and Non-Profit deal trends since 2012
  • Access to headline, upfront, milestone and royalty data
  • Analysis of the structure of Academic and Non-Profit agreements with real life case studies
  • Detailed access to actual Academic and Non-Profit contracts entered into by leading biopharma companies
  • Identify most active Academic and Non-Profit dealmakers since 2012
  • Insight into terms included in a Academic and Non-Profit partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

  • Trends in Academic and Non-Profit dealmaking in the biopharma industry since 2012
  • Analysis of Academic and Non-Profit deal structure
  • Access to headline, upfront, milestone and royalty data
  • Case studies of real-life Academic and Non-Profit deals
  • Access to Academic and Non-Profit contract documents
  • Leading Academic and Non-Profit deals by value since 2012
  • Most active Academic and Non-Profit dealmakers since 2012

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Academic and Non-Profit dealmaking

2.1. Introduction
2.2. Academic and Non-Profit partnering over the years
2.3. Most active Academic and Non-Profit dealmakers
2.4. Academic and Non-Profit partnering by deal type
2.5. Academic and Non-Profit partnering by therapy area
2.6. Academic and Non-Profit partnering by technology type
2.7. Deal terms for Academic and Non-Profit partnering
2.7.1 Academic and Non-Profit partnering headline values
2.7.2 Academic and Non-Profit deal upfront payments
2.7.3 Academic and Non-Profit deal milestone payments
2.7.4 Academic and Non-Profit royalty rates

Chapter 3 - Leading Academic and Non-Profit deals

3.1. Introduction
3.2. Top Academic and Non-Profit deals by value

Chapter 4 - Most active Academic and Non-Profit dealmakers

4.1. Introduction
4.2. Most active Academic and Non-Profit dealmakers
4.3. Most active Academic and Non-Profit partnering company profiles

Chapter 5 - Academic and Non-Profit contracts dealmaking directory

5.1. Introduction
5.2. Academic and Non-Profit contracts dealmaking directory

Chapter 6 - Academic and Non-Profit dealmaking by technology type

Chapter 7 - Partnering resource center

7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

For more information about this report visit https://www.researchandmarkets.com/research/v8gnfz/global_pharma?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-pharma-academic-and-non-profit-partnering-report-2018-access-to-actual-contracts-by-leading-biopharma-companies-since-2012-300786022.html

SOURCE Research and Markets

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!